The younger a woman is diagnosed with MS, the greater chance she has of going 2 or more decades without significant progression
Slow MS Progress Most Likely if Diagnosed Young This report is part of a 12-month Clinical Context series. By Ed Susman,…
Protein block `could halt multiple sclerosis`
Washington: Scientists claim to have discovered that the progress of debilitating disease multiple sclerosis could be slowed or even stopped…
Stuart Schlossman
Patients Drop MS Drug (Tysabri), Face Relapse Risk
This report is part of a 12-month Clinical Context series. By John Gever, Senior Editor, MedPage Today Published: April 25, 2012…
Stuart Schlossman
Acorda says MS drug (AMPYRA) benefits lasted up to 5 years
HAWTHORNE, N.Y. Acorda Therapeutics Inc. said Wednesday that clinical study data shows its multiple sclerosis drug Ampyra continued to help…
Stuart Schlossman
New MS Drugs Will Give Patients More Options
By John Gever, Senior Editor, MedPage Today Published: April 25, 2012 NEW ORLEANS — Investigational multiple sclerosis drugs moving through the…
Stuart Schlossman
Learn what Stu’s Views and MS News / MS Views and News is doing Globally
Read to below to learn of MS VIews and News. THEN REGISTER! It takes less than 30 seconds to register and…
Stuart Schlossman
Links to help you to understand more of Multiple Sclerosis
Links to help you to better understand why research and education is needed What is Multiple Sclerosis Early…
Stuart Schlossman
MS Awareness month brings organizations together, benefiting those affected by Multiple Sclerosis
March 1, 2012 MSVN is partnering with the MSF to provide much needed educational information to the Multiple Sclerosis Community…
Stuart Schlossman
A CLINICAL trial will test whether Vitamin D can help fight multiple sclerosis (MS)
Vitamin D could be THE weapon against MS February 22nd, 2012 If successful, researchers say the trial could open the…
Stuart Schlossman
You Still have 10 days
Dear Friends, The end of 2011 is approaching, but you still have 10 days to make one last gift this…
Stuart Schlossman
